Compare Adaptive Biotechnologies Corp (ADPT) vs Coursera Inc (COUR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adaptive Biotechnologies Corp vs Coursera Inc — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while Coursera Inc trades at $5.65 (market cap $1.50B). The key difference: Adaptive Biotechnologies Corp is far larger — about 2.7× Coursera Inc's market cap, and Adaptive Biotechnologies Corp is trading nearer its 52-week high, Coursera Inc nearer its low. Which is the better fit depends on your goals.
| ADPT | COUR | |
|---|---|---|
Market Cap | $4.04B | $1.50B |
Sector | Health | Consumer Staples |
52-Week High | $25.45 | $12.20 |
52-Week Low | $12.30 | $5.09 |
Enterprise Value | $4.10B | $759.54M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adaptive Biotechnologies Corp
Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Read more on ADPT →About Coursera Inc
Coursera Inc is a global online learning platform that offers anyone, anywhere access to online courses and degrees from world-class universities and companies. It combines content, data, and technology into a single, unified platform that is customizable and extensible to both individual learners and institutions. The platform will contain a catalog of high-quality content and credentials, content developed by leading university and industry partners, data and machine learning drive personalized Learning, effective marketing, and skills Benchmarking and others.
Read more on COUR →
